Insider Selling: Phreesia, Inc. (NYSE:PHR) Director Sells 861 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) Director Michael Weintraub sold 861 shares of the business's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $25.26, for a total value of $21,748.86. Following the transaction, the director now directly owns 242,827 shares in the company, valued at $6,133,810.02. This trade represents a 0.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Michael Weintraub also recently made the following trade(s):

• On Friday, December 13th, Michael Weintraub sold 20,565 shares of Phreesia stock. The shares were sold at an average price of $25.04, for a total value of $514,947.60.
• On Monday, December 2nd, Michael Weintraub sold 15,152 shares of Phreesia stock. The stock was sold at an average price of $21.01, for a total value of $318,343.52.

Phreesia Stock Down 3.0 %

Phreesia stock traded down $0.77 during mid-day trading on Tuesday, hitting $24.87. The company's stock had a trading volume of 463,410 shares, compared to its average volume of 450,575. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.16. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. The company has a market cap of $1.45 billion, a PE ratio of -17.46 and a beta of 0.98. The firm's 50 day moving average is $20.53 and its 200 day moving average is $21.84.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. During the same period in the prior year, the company posted ($0.58) EPS. The company's revenue was up 16.6% compared to the same quarter last year. On average, analysts anticipate that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Analyst Ratings Changes

PHR has been the subject of a number of research reports. JPMorgan Chase & Co. boosted their price target on shares of Phreesia from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Monday, September 9th. Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a report on Wednesday, December 11th. JMP Securities reiterated a "market outperform" rating and set a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Needham & Company LLC reissued a "buy" rating and issued a $29.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Finally, Truist Financial lifted their price objective on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $29.33.

Institutional Investors Weigh In On Phreesia

Large investors have recently added to or reduced their stakes in the business. Deerfield Management Company L.P. Series C bought a new position in Phreesia in the 2nd quarter valued at approximately $4,078,000. Champlain Investment Partners LLC increased its stake in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company's stock worth $57,062,000 after purchasing an additional 97,847 shares during the last quarter. Sei Investments Co. lifted its position in shares of Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company's stock worth $3,505,000 after acquiring an additional 95,058 shares in the last quarter. Squarepoint Ops LLC raised its holdings in shares of Phreesia by 56.3% in the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company's stock valued at $5,308,000 after acquiring an additional 90,215 shares in the last quarter. Finally, State Street Corp lifted its stake in shares of Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after acquiring an additional 88,517 shares during the last quarter. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.